Daniel Lin, MD

Dr. Daniel Lin is a prostate cancer researcher and professor of urology who specializes in the surgical treatment of genitourinary cancers, or malignancies of the reproductive organs and urinary system. He serves as chief of Urologic Oncology at the University of Washington and treats patients at Fred Hutchinson Cancer Center. His research focuses on early detection and prevention of aggressive prostate cancer (including metastatic recurrence) with a particular interest in biomarkers, as well as new imaging and ablative technologies and treatments for the disease. Dr. Lin has participated in studies to understand inherited risk of prostate cancer and how lifestyle modifications such as in diet and exercise may affect prostate cancer biology. As the director of the Institute for Prostate Cancer Research, he supports studies in the use of genomics and DNA sequencing in cancer care, strategies to harness the body’s immune system to fight cancer via new immunotherapies, and the development of advanced imaging techniques to help with the daily management of patients with early- and late-stage prostate cancer. Dr. Lin also chairs the Localized Prostate Cancer Committee of the SWOG Cancer Research Network and is active in the development of prostate cancer clinical trials.